Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 May 18;18(10):5362.
doi: 10.3390/ijerph18105362.

Why Does Israel Lead the World in COVID-19 Vaccinations? Applying Mass Casualty Event Principles to COVID-19 Vaccination Programs

Carmit Rapaport  1   2 , Isaac Ashkenazi  1   3
Affiliations

Why Does Israel Lead the World in COVID-19 Vaccinations? Applying Mass Casualty Event Principles to COVID-19 Vaccination Programs

Carmit Rapaport et al. Int J Environ Res Public Health. .

Abstract

The article examines Israel's experience in managing the COVID-19 vaccination program beginning in December 2020. Utilizing principles of mass casualty event management, such as triaging, flow of casualty care, and flexibility (among others), we analyze Israel's vaccination program. The successful Israeli experience was found to be based on timely coordinated and adaptive health system logistics and operations, as well as cooperative population behaviors.

Keywords: COVID-19; Israel; crisis management; mass casualty events; population behavior; vaccination.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Components of emergency response during uncertainty.
Figure 2
Figure 2
Example of a Vaccination Certificate.
See this image and copyright information in PMC

References

    1. Rapaport C., Ashkenazi I. Managing COVID-19: Applying an Asymmetric Solution to an Asymmetric Problem. J. Emerg. Med Serv. 2020;361:1651–1661.
    1. Ashkenazi I., Rapaport C. Saving Lives Versus Saving Dollars: The Acceptable Loss for Corona-virus Disease 2019. Crit. Care Med. 2020;48:1243–1244. doi: 10.1097/CCM.0000000000004452. - DOI - PMC - PubMed
    1. Excler J.-L., Saville M., Berkley S., Kim J.H. Vaccine development for emerging infectious diseases. Nat. Med. 2021;27:591–600. doi: 10.1038/s41591-021-01301-0. - DOI - PubMed
    1. Ashkenazi I., Basavaraju S.V., Garbarino L.T., Hunt R.C., Kapil V., McGuire L.C., Peters P.S., Sasser S.M., Sullivent E.E. Interim Planning Guidance for Preparedness and Response to a Mass Casualty Event Resulting from Terrorist Use of Explosives. National Center for Injury Prevention and Control, Division of Injury Response; Atlanta, GA, USA: 2010.
    1. Marcus L.J., Dorn B.C., Ashkenazi I., Henderson J.M., McNulty E.J. Crisis Preparedness and Crisis Response: The Meta-Leadership Model and Method. The McGraw Hill Homeland Security Handbook. McGraw-Hill; New York, NY, USA: 2012. pp. 679–710.

Substances